| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/17/2003 | US20030134303 Adenine nucleotide-binding protein-directed probes, and methods of their synthesis and use |
| 07/17/2003 | US20030134301 Nucleic acids, their expression products and pathways involved in pain, and their use in screening for molecule that can alleviate pain |
| 07/17/2003 | US20030134300 MLL translocations specify a distinct gene expression profile, distinguishing a unique leukemia |
| 07/17/2003 | US20030134299 Surface saturation surfaces; hybrid nucleic acid |
| 07/17/2003 | US20030134295 Cell differentiation; amplification; hybridization |
| 07/17/2003 | US20030134293 Coupling oligonucleotide to nucleic acid; amplification, sequence determination |
| 07/17/2003 | US20030134292 Thermostable DNA polymerases and methods of making same |
| 07/17/2003 | US20030134291 Polymorphism detection |
| 07/17/2003 | US20030134290 Method for identifying polymorphisms |
| 07/17/2003 | US20030134289 Identifying and purifying double-stranded polynucleotides lacking base pair mismatches, insertion/deletion loops and/or nucleotide gaps and polypeptide coding sequences and gene constructs. |
| 07/17/2003 | US20030134285 Determination ethnic origin of male using polymorphic markers |
| 07/17/2003 | US20030134284 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134283 Genes regulated in dendritic cell differentiation |
| 07/17/2003 | US20030134282 Quantitative analysis of tissue gene expression; amplification; polymerase chain reaction |
| 07/17/2003 | US20030134281 Nanomachine compositions and methods of use |
| 07/17/2003 | US20030134280 Identifying drugs for and diagnosis of benign prostatic hyperplasia using gene expression profiles |
| 07/17/2003 | US20030134279 Using topoisomerase inhibitor |
| 07/17/2003 | US20030134278 Chromosome inheritance modifiers and their uses |
| 07/17/2003 | US20030134277 Analyzing pattern labels; receptor binding analysis |
| 07/17/2003 | US20030134276 Complex mixture of nucleic acids, wherein truncated DNA molecules as well as DNA molecules of full length are synthesized simultaneously and exponentially between two positions on the said DNA molecule, which initially contains |
| 07/17/2003 | US20030134274 Nucleic acid sequence detection employing probes comprising non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents |
| 07/17/2003 | US20030134272 Mutation analysis of the NF1 gene |
| 07/17/2003 | US20030134270 Rapid method of selecting cells for gene disruption by homologous recombination |
| 07/17/2003 | US20030134268 Fast and exhaustive method for selecting a prey polypeptide interacting with a bait polypeptide of interest: application to the construction of maps of interactors polypeptides |
| 07/17/2003 | US20030134265 Screening method for nucleic acids |
| 07/17/2003 | US20030134263 Controlling gene expression; transfection of cell |
| 07/17/2003 | US20030133949 Providing bacteria which are modified to produce first signal, exposure the the material being evaluated to the bacteria on fisrst side to determine whether the first signal is present on second side or within the material |
| 07/17/2003 | US20030133948 An expression vector, comprising a) coding sequences for i) the viral nucleic acid-binding protein LANA ii) a therapeutic gene, and b) viral nucleic acid to which above viral nucleic acid-binding protein will bind |
| 07/17/2003 | US20030133931 Combining a putative modulator compound of mammalian histamine H4 receptor protein activity with mammalian histamine H4 receptor protein and a known histamine receptor H4 ligand, measuring the effect of the modulator on the protein |
| 07/17/2003 | US20030133915 Appling hydrostatic pressure |
| 07/17/2003 | US20030133913 Producing chemokine receptors, inducing antigen by dendritic cells in vitro, for therapeutic or prophylactic purposes |
| 07/17/2003 | US20030133910 Inhibiting cell proliferation by administering a large dosage of wild-type ras proteins |
| 07/17/2003 | US20030133875 Assay for screening candidate drug for the treatment of inflammatory diseases and methods for treating the same |
| 07/17/2003 | US20030133123 Sensor formulation for the detection of gas composition and method of making same |
| 07/17/2003 | US20030132110 Whole blood is measured, wherein plasma of blood, with hemocytes thereof having been filtered out, is allowed to quickly reach an electrode system; high speed, accuracy |
| 07/17/2003 | US20030132109 Pipette configurations and arrays thereof for measuring cellular electrical properties |
| 07/17/2003 | CA2473379A1 Methods of detecting hcv genotype 1 (hcv-1) by using primers specific for the 5' non-coding region (ncr) of the hcv genome |
| 07/17/2003 | CA2473226A1 Diagnostics and vaccines for mycrobacterium paratuberculosis infections |
| 07/17/2003 | CA2472646A1 Genetic analysis systems and methods |
| 07/17/2003 | CA2472282A1 Gene products differentially expressed in cancerous breast cells and their methods of use |
| 07/17/2003 | CA2472193A1 Quantitative ranking of transient ligand binding to target biomolecules |
| 07/17/2003 | CA2472118A1 Pak5-related compositions and methods |
| 07/17/2003 | CA2472111A1 Human mast cell-expressed membrane proteins |
| 07/17/2003 | CA2472026A1 Method for detecting human papillomavirus mrna |
| 07/17/2003 | CA2471840A1 Novel compositions and methods for cancer |
| 07/17/2003 | CA2471750A1 Polyphenol inhibition of nucleoside diphosphate kinase-b activity and cancer metastasis |
| 07/17/2003 | CA2471691A1 Multianalyte molecular analysis using application-specific random particle arrays |
| 07/17/2003 | CA2471582A1 Automated systems and methods for analysis of protein post-translational modification |
| 07/17/2003 | CA2471504A1 Ligand for g-protein coupled receptor gpr43 and uses thereof |
| 07/17/2003 | CA2471214A1 The use of histamine h4 receptor antagonist for the treatment of inflammatory response |
| 07/17/2003 | CA2470411A1 System for monitoring bacterial tumor treatment |
| 07/17/2003 | CA2470389A1 Use of cytokines secreted by dendritic cells |
| 07/17/2003 | CA2470277A1 Inducible transposition in transgenic organism using transposon vector |
| 07/17/2003 | CA2470012A1 Novel proteins and nucleic acids encoding same |
| 07/17/2003 | CA2469480A1 Use of biomolecular targets in the treatment and visualization of tumors |
| 07/17/2003 | CA2468888A1 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
| 07/17/2003 | CA2467083A1 Viral capsid assembly intermediates |
| 07/17/2003 | CA2457407A1 Light-directed molecular analysis for cancer prognosis and diagnosis |
| 07/17/2003 | CA2450814A1 Microarrays for cell phenotyping and manipulation |
| 07/16/2003 | EP1327881A1 Hollow electrochemical cell |
| 07/16/2003 | EP1327874A2 Sensor formulation for the detection of gas composition and method for making same |
| 07/16/2003 | EP1327691A2 Detection of respiratory viruses |
| 07/16/2003 | EP1327690A2 Solid phase method for analyzing a biomolecule |
| 07/16/2003 | EP1327685A1 Bzip transcripiton factors that controls expression of the storage protein in the rice plant |
| 07/16/2003 | EP1327683A2 Human papilloma virus inhibition by a hairpin ribozyme |
| 07/16/2003 | EP1327679A1 Method of synthesizing polynucleotide |
| 07/16/2003 | EP1327639A1 Prediction of cardiovascular disease by genetic polymorphisms in cardiovascular associated genes |
| 07/16/2003 | EP1327473A1 Method of stirring reaction solutions |
| 07/16/2003 | EP1327151A2 Methods for characterizing molecular interactions using affinity capture tandem mass spectrometry |
| 07/16/2003 | EP1327150A1 Methods for detecting modulators of ion channels using thallium (i) sensitive assays |
| 07/16/2003 | EP1327149A2 Methods of high-throughput screening for internalizing antibodies |
| 07/16/2003 | EP1327146A2 Compounds with a branched linker |
| 07/16/2003 | EP1327005A2 Method for selecting nucleic acids that bond with high-affinity to a target |
| 07/16/2003 | EP1327004A2 Method for detecting at least one nucleic acid sequence |
| 07/16/2003 | EP1327003A2 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products |
| 07/16/2003 | EP1327001A2 Method of amplifying nucleic acids providing means for strand separation and universal sequence tags |
| 07/16/2003 | EP1327000A2 Transposon mediated multiplex sequencing |
| 07/16/2003 | EP1326999A2 A nucleic acid-based method for tree phenotype prediction |
| 07/16/2003 | EP1326998A2 Cd38 modulated chemotaxis |
| 07/16/2003 | EP1326997A2 Model for neurodegenerative diseases involving amyloid accumulation |
| 07/16/2003 | EP1326996A1 Id-1 and id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma |
| 07/16/2003 | EP1326990A2 Packaging of positive-strand rna virus replicon particles |
| 07/16/2003 | EP1326986A2 Regulation of human sphingosine kinase-like protein |
| 07/16/2003 | EP1326976A1 Mfq-114, a human ajuba like protein |
| 07/16/2003 | EP1326972A2 Transporters and ion channels |
| 07/16/2003 | EP1326971A2 Proteins and nucleic acids encoding same |
| 07/16/2003 | EP1326970A2 Rapid profiling of the interactions between a chemical entity and proteins in a given proteome |
| 07/16/2003 | EP1326963A2 Nucleic acid amplification controls |
| 07/16/2003 | EP1326961A2 Compositions and methods for inducing specific cytolytic t cell responses |
| 07/16/2003 | EP1326957A2 Method for the prevention or reduction of haze in beverages |
| 07/16/2003 | EP1326895A1 Monoclonal antibodies directed against hepatitis b viruses |
| 07/16/2003 | EP1326894A2 Novel tumor-associated marker |
| 07/16/2003 | EP1326891A1 Gene encoding a human g-protein coupled receptor and its use |
| 07/16/2003 | EP1326882A2 Enterokinase cleavage sequences and their use |
| 07/16/2003 | EP1326881A1 PREPARATION OF CAPPED mRNA |
| 07/16/2003 | EP1326707A2 High density arrays |
| 07/16/2003 | EP1326653A2 Detection of the presence of a microbe or related substance at a location |
| 07/16/2003 | EP1326640A2 Non-nucleoside reverse transcriptase inhibitor as antiretroviral therapy |
| 07/16/2003 | EP1326597A2 Methods for modulating bladder function |
| 07/16/2003 | EP1326523A2 Imaging of enzymatic activity |